Evidence map›Paper›PMID 40521061›Full record

ReviewPostepy dermatologii i alergologii2025

Atopic dermatitis and non-alcoholic fatty liver disease: current state of evidence and possible pathogenetic correlations.

Marta Dębicka, Aleksandra Bąk, Jerzy Walecki, Irena Walecka

Abstract readReview
In one paragraph

Review in Postepy dermatologii i alergologii, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Marta DębickaCentre of Radiological Diagnostics, The National Institute of Medicine of the Ministry of the Interior and Administration, Warsaw, Poland.
Aleksandra BąkDermatology Department, The National Institute of Medicine of the Ministry of the Interior and Administration, Warsaw, Poland.
Jerzy WaleckiCentre of Radiological Diagnostics, The National Institute of Medicine of the Ministry of the Interior and Administration, Warsaw, Poland.
Irena WaleckaDermatology Department, The National Institute of Medicine of the Ministry of the Interior and Administration, Warsaw, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Relationships between inflammatory diseases and metabolic abnormalities are recently raising much scientific interest. Convincing evidence on the association between atopic dermatitis (AD) and constituents of metabolic syndrome (MS) has already been established. In this article we aim to summarize current data on the link between AD and non-alcoholic fatty liver disease (NAFLD), which is considered a hepatic manifestation of MS. By reviewing animal models, human studies and possible pathogenetic points of contiguity we want to present the current state of knowledge and goals for further investigations. To our best knowledge, this is the first review of this topic so far.

Indexed as

atopic dermatitisgut-skin axisliver steatosisnon-alcoholic fatty liver disease

Identifiers

PMID40521061
PMCPMC12163961

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.